Literature DB >> 10591766

[Optimal timing for secondary surgery in polytrauma patients: an evaluation of 4,314 serious-injury cases].

H Pape1, M Stalp, M v Griensven, A Weinberg, M Dahlweit, H Tscherne.   

Abstract

INTRODUCTION: It has been argued that secondary operations in multiple trauma patients impose an additional systemic burden, representing an additional risk of organ dysfunction. We investigated whether the timing of a secondary operation of > 3 h duration is related with the development of organ dysfunction.
METHODS: In a retrospective analysis, 4,314 polytrauma patients treated at our institution between January 1975 and January 1999 were investigated. Patients were divided according to the presence ( + MOF) or absence (-MOF) of organ failure (Goris' criteria).
RESULTS: In both groups, the injury severity, rescue time, duration and incidence of primary operations were comparable. Secondary surgery in patients who later developed organ failure was significantly more often performed between day 2 and 4, whereas patients without organ failure were usually operated between day 6 and 8 (P < 0.0001). The initial laboratory data in these two groups were comparable. If patients with organ failure were operated on days 6-8, significantly worse initial laboratory data were determined, indicating that these patients were at high risk of developing MOF.
CONCLUSION: In patients with severe trauma requiring secondary operations of > 3 h duration, performance of this operation should be avoided on post trauma days 2-4.

Entities:  

Mesh:

Year:  1999        PMID: 10591766     DOI: 10.1007/s001040050781

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  18 in total

Review 1.  [Management of spine injuries in polytraumatized patients].

Authors:  C E Heyde; W Ertel; R Kayser
Journal:  Orthopade       Date:  2005-09       Impact factor: 1.087

2.  Femoral nailing-related coagulopathy determined by first-hit magnitude: an animal study.

Authors:  Peter V Giannoudis; Martijn van Griensven; Frank Hildebrand; Christian Krettek; Hans-Christoph Pape
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

Review 3.  [Strategies for surgical treatment of multiple trauma including pelvic fracture. Review of the literature].

Authors:  M Burkhardt; U Culemann; A Seekamp; T Pohlemann
Journal:  Unfallchirurg       Date:  2005-10       Impact factor: 1.000

Review 4.  Immune depression in musculoskeletal trauma.

Authors:  Olav Reikerås
Journal:  Inflamm Res       Date:  2010-02-11       Impact factor: 4.575

Review 5.  [Current concepts of polytrauma management: from ATLS to "damage control"].

Authors:  P F Stahel; C E Heyde; W Wyrwich; W Ertel
Journal:  Orthopade       Date:  2005-09       Impact factor: 1.087

Review 6.  [Decision making and and priorities for surgical treatment during and after shock trauma room treatment].

Authors:  H C Pape; F Hildebrand; C Krettek
Journal:  Unfallchirurg       Date:  2004-10       Impact factor: 1.000

7.  Influence of surgical intervention in the immune response of severely injured patients.

Authors:  Sascha Flohé; Sven Lendemans; Fritz-Ulrich Schade; Ernst Kreuzfelder; Christian Waydhas
Journal:  Intensive Care Med       Date:  2003-11-07       Impact factor: 17.440

8.  The effect of evolving trauma care on the development of multiple organ dysfunction syndrome.

Authors:  K J P van Wessem; L P H Leenen
Journal:  Eur J Trauma Emerg Surg       Date:  2014-03-16       Impact factor: 3.693

Review 9.  Immune response of severely injured patients--influence of surgical intervention and therapeutic impact.

Authors:  S Flohé; S B Flohé; F U Schade; C Waydhas
Journal:  Langenbecks Arch Surg       Date:  2007-06-29       Impact factor: 3.445

10.  Management of Grade 3C Compound Injury of Lower Limb with Floating Knee - Salvage versus Amputation (Case Series).

Authors:  Sundar Suriyakumar; Sharandeep Singh Saluja; Muthumanickam Ramanujam; Muhammed Niyas Mancheri; N Jambu
Journal:  J Orthop Case Rep       Date:  2021-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.